Clinical trial

Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the…

NCT02579499 · Yonsei University, Other · Unknown status

Key facts

NCT number NCT02579499
Title Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease
Official title Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease: a Randomized Comparison Trial
Acronym LODESTAR
Lead sponsor Yonsei University, Other
Status Unknown status
Phase Phase 4
Study type Interventional
Conditions Coronary Artery Diseasse
Intervention type Drug
Interventions fixed high potent statin therapy, targeted LDL-C goal statin
Enrollment 4,400
Start date Sep 9, 2016
Primary completion Nov 1, 2022
Completion Nov 1, 2022
First posted Oct 19, 2015
Last update posted Nov 30, 2022
Countries South Korea

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies